Cholesterol, statins, and longevity from age 70 to 90 years
- PMID: 24094647
- DOI: 10.1016/j.jamda.2013.08.012
Cholesterol, statins, and longevity from age 70 to 90 years
Abstract
Background: The importance of cholesterol as a risk factor among older people, particularly among the very old, is controversial. Whether or not hypercholesterolemia warrants medical concern, and whether statins are beneficial among very old people, remain unresolved common clinical dilemmas. This study examines whether increased total cholesterol (TC) was associated with higher mortality from age 70 to 90, and if statins had a protective effect.
Methods: A representative sample (born 1920-1921) from the Jerusalem Longitudinal Cohort Study (1990-2010) was assessed at ages 70, 78, and 85 for fasting serum TC, low-density (LDL), and high-density lipoprotein (LDL); triglycerides; statin usage; social, functional, and medical domains; and all-cause mortality data (1990-2010). TC was analyzed as either continuous (10 mg/dL increments) or dichotomous variable (high TC >200 mg/dL). Cox proportional hazards models determined mortality hazard ratios (HRs), adjusting for TC, statin treatment, gender, self-rated health, smoking, hypertension, diabetes, ischemic heart disease, neoplasm, body mass index, albumin, and triglycerides.
Results: Prevalence of high TC at ages 70, 78, and 85 was 75% (n = 344), 65% (n = 332), and 34% (n = 237), and statin use was 0%, 17.9%, and 45.4%, respectively. Survival was increased (not significantly) among subjects with high TC >200 mg/dL versus ≤200 mg/dL from ages 70 to 78, 78 to 85, and 85 to 90: 79.1% versus 73.3% (log rank P = .16), 68.7% versus 61.5% (P = .10), and 73.4% versus 70.3% (P = .45), respectively. Survival was significantly increased among subjects treated with statins versus no statins at ages 78 to 85 (74.7% vs 64.3%, log rank P = .07) and 85 to 90 (76.2% vs 67.4%, P = .01). After adjustment, TC (continuous or dichotomous) was not associated with mortality from 70 to 78, 78 to 85, or 85 to 90. In contrast, statins at age 85 were associated with decreased mortality from age 85 to 90 (adjusted HR 0.61, 95% confidence interval 0.42-0.89).
Conclusions: Among older people, cholesterol levels were unrelated to mortality between the ages of 70 and 90. The protective effect of statins observed among the very old appears to be independent of TC.
Keywords: Cholesterol; longevity; longitudinal cohort study; oldest old; statins.
Copyright © 2013 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Statins and the nursing home.J Am Med Dir Assoc. 2013 Dec;14(12):853-4. doi: 10.1016/j.jamda.2013.09.016. J Am Med Dir Assoc. 2013. PMID: 24286708 No abstract available.
Similar articles
-
Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.Cerebrovasc Dis. 2012;34(3):213-20. doi: 10.1159/000342302. Epub 2012 Sep 18. Cerebrovasc Dis. 2012. PMID: 23006641
-
Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol.Am J Cardiol. 2017 Dec 1;120(11):1947-1954. doi: 10.1016/j.amjcard.2017.08.011. Epub 2017 Aug 30. Am J Cardiol. 2017. PMID: 28951019
-
Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.Am J Cardiol. 2006 Sep 1;98(5):653-8. doi: 10.1016/j.amjcard.2006.03.046. Epub 2006 Jul 7. Am J Cardiol. 2006. PMID: 16923455
-
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. J Manag Care Pharm. 2008. PMID: 19891279 Review.
-
Statin effects on both low-density lipoproteins and high-density lipoproteins: is there a dual benefit?Curr Atheroscler Rep. 2010 Jan;12(1):14-9. doi: 10.1007/s11883-009-0085-8. Curr Atheroscler Rep. 2010. PMID: 20425266 Review.
Cited by
-
Discontinuation of Statins: What Are the Risks?Curr Atheroscler Rep. 2016 Jul;18(7):41. doi: 10.1007/s11883-016-0596-z. Curr Atheroscler Rep. 2016. PMID: 27221503 Review.
-
Antiaging agents: safe interventions to slow aging and healthy life span extension.Nat Prod Bioprospect. 2022 May 9;12(1):18. doi: 10.1007/s13659-022-00339-y. Nat Prod Bioprospect. 2022. PMID: 35534591 Free PMC article. Review.
-
From rapalogs to anti-aging formula.Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033. Oncotarget. 2017. PMID: 28548953 Free PMC article. Review.
-
Information theoretical analysis of aging as a risk factor for heart disease.Aging Dis. 2015 Jun 1;6(3):196-207. doi: 10.14336/AD.2014.0623. eCollection 2015 Jun. Aging Dis. 2015. PMID: 26029478 Free PMC article.
-
Low and High-Density Lipoprotein Cholesterol and 10-Year Mortality in Community-Dwelling Older Adults: The Shanghai Aging Study.Front Med (Lausanne). 2022 Mar 8;9:783618. doi: 10.3389/fmed.2022.783618. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35355605 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
